Ubica Lifesciences Private Limited, a active private limited company, was established on 05 July 2020 in Hyderabad, Telangana, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24119TG2020PTC141425. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.
Its leadership includes Hemlata Sharma (Director), Ajay Shanker Sharma (Director), Aditya Sharma (Additional Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 55,Ground Floor,Infinity Homes Tellapur, Rangareddi, Hyderabad, Telangana, 500032.
U24119TG2020PTC141425
141425
05 July 2020
₹1.50 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Ubica Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hemlata Sharma | Director | 05 Jul 2020 | Current |
| Ajay Shanker Sharma | Director | 05 Jul 2020 | Current |
| Aditya Sharma | Additional Director | 23 Sep 2025 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ubica Lifesciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 40.3% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.01%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Ubica Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Ubica Lifesciences has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ubica Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ubica Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Aditya Sharma was appointed as a Additional Director was appointed as a Additional Director on 23 Sep 2025 & has been associated with this company since 3 months 6 days . was documented.
Progress on Ubica Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Ubica Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Hemlata Sharma was appointed as a Director was appointed as a Director on 05 Jul 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.
The activity Ajay Shanker Sharma was appointed as a Director was appointed as a Director on 05 Jul 2020 & has been associated with this company since 5 years 5 months . was completed.
The activity Ubica Lifesciences Private Limited was registered on 05 Jul 2020 with Roc Hyderabad & aged 5 years 5 months as per MCA records. was completed.
The CIN of Ubica Lifesciences Private Limited is U24119TG2020PTC141425.
Ubica Lifesciences Private Limited is headquartered at Plot No. 55,Ground Floor,Infinity Homes Tellapur, Rangareddi, Hyderabad, Telangana, 500032.
Ubica Lifesciences Private Limited was incorporated on 05 July 2020.
The current directors of Ubica Lifesciences Private Limited are
The primary industry of Ubica Lifesciences Private Limited is Chemicals.
Ubica Lifesciences Private Limited is unlisted.
The authorized capital of Ubica Lifesciences Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX